Beijing Centergate Technologies Holding Co Ltd Total Liabilities

Latest as of September 2025: CN¥1.95 Billion CNY ≈ $285.29 Million USD

Beijing Centergate Technologies Holding Co Ltd total liabilities. Based on the latest financial reports, Beijing Centergate Technologies Holding Co Ltd (000931) has total liabilities worth CN¥1.95 Billion CNY (≈ $285.29 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000931 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Beijing Centergate Technologies Holding Co Ltd (1996–2024)

Total liabilities of Beijing Centergate Technologies Holding Co Ltd from 1996 to 2024. This chart illustrates how Beijing Centergate Technologies Holding Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 000931 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Beijing Centergate Technologies Holding Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Centergate Technologies Holding Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
African Gold Ltd
AU:A1G
Australia AU$3.23 Million
Sports Toto Berhad
KLSE:1562
Malaysia RM2.52 Billion
LUBAWA SA
WAR:LBW
Poland zł151.17 Million
Hanjia Design Croup Co Ltd Class A
SHE:300746
China CN¥2.40 Billion
Yantai Ishikawa Sealing Technology Co.Ltd.
SHE:301020
China CN¥239.17 Million
Shanghai Fudan Forward S&T Co Ltd
SHG:600624
China CN¥828.67 Million
Mahindra Holidays & Resorts India Limited
NSE:MHRIL
India Rs102.45 Billion
Byggmax Group AB
ST:BMAX
Sweden Skr3.40 Billion

Liability Composition Analysis (1996–2024)

This chart breaks down Beijing Centergate Technologies Holding Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 000931 asset base.

Liquidity & Leverage Metrics

Beijing Centergate Technologies Holding Co Ltd Total Liabilities Ratios Explained

Beijing Centergate Technologies Holding Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.27 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Centergate Technologies Holding Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Centergate Technologies Holding Co Ltd (1996–2024)

The table below shows the annual total liabilities of Beijing Centergate Technologies Holding Co Ltd from 1996 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥1.91 Billion
≈ $278.77 Million
-6.68%
2023-12-31 CN¥2.04 Billion
≈ $298.74 Million
+9.15%
2022-12-31 CN¥1.87 Billion
≈ $273.70 Million
-0.71%
2021-12-31 CN¥1.88 Billion
≈ $275.65 Million
+21.98%
2020-12-31 CN¥1.54 Billion
≈ $225.97 Million
-10.48%
2019-12-31 CN¥1.73 Billion
≈ $252.44 Million
+5.55%
2018-12-31 CN¥1.63 Billion
≈ $239.17 Million
-12.05%
2017-12-31 CN¥1.86 Billion
≈ $271.95 Million
-10.66%
2016-12-31 CN¥2.08 Billion
≈ $304.39 Million
+9.56%
2015-12-31 CN¥1.90 Billion
≈ $277.82 Million
+4.18%
2014-12-31 CN¥1.82 Billion
≈ $266.68 Million
-50.88%
2013-12-31 CN¥3.71 Billion
≈ $542.90 Million
+10.21%
2012-12-31 CN¥3.37 Billion
≈ $492.61 Million
-4.93%
2011-12-31 CN¥3.54 Billion
≈ $518.13 Million
+12.91%
2010-12-31 CN¥3.14 Billion
≈ $458.87 Million
+6.31%
2009-12-31 CN¥2.95 Billion
≈ $431.64 Million
-8.31%
2008-12-31 CN¥3.22 Billion
≈ $470.77 Million
-15.27%
2007-12-31 CN¥3.80 Billion
≈ $555.61 Million
+0.14%
2006-12-31 CN¥3.79 Billion
≈ $554.83 Million
-9.31%
2005-12-31 CN¥4.18 Billion
≈ $611.78 Million
-7.70%
2004-12-31 CN¥4.53 Billion
≈ $662.82 Million
-25.74%
2003-12-31 CN¥6.10 Billion
≈ $892.59 Million
+13.63%
2002-12-31 CN¥5.37 Billion
≈ $785.53 Million
-27.27%
2001-12-31 CN¥7.38 Billion
≈ $1.08 Billion
+64.92%
2000-12-31 CN¥4.48 Billion
≈ $654.86 Million
+198.99%
1999-12-31 CN¥1.50 Billion
≈ $219.02 Million
+67.38%
1998-12-31 CN¥894.21 Million
≈ $130.85 Million
-14.95%
1997-12-31 CN¥1.05 Billion
≈ $153.86 Million
+4.39%
1996-12-31 CN¥1.01 Billion
≈ $147.38 Million
--

About Beijing Centergate Technologies Holding Co Ltd

SHE:000931 China Medical Instruments & Supplies
Market Cap
$418.78 Million
CN¥2.86 Billion CNY
Market Cap Rank
#12872 Global
#3754 in China
Share Price
CN¥3.80
Change (1 day)
+1.60%
52-Week Range
CN¥3.73 - CN¥5.70
All Time High
CN¥12.90
About

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more